An in-depth look at this medical topic, providing essential context for patients and caregivers.
General Medical Overview
Angiosarcoma: A condition categorized under Sarcomas (Bone & Soft Tissue).
Angiosarcoma is a rare, aggressive malignancy of vascular endothelial cells, representing less than 2% of all soft tissue sarcomas. It can occur in any body site but has a predilection for the skin/scalp (most common), breast (especially post-radiation), liver, and deep soft tissues. Cutaneous angiosarcoma of the scalp in elderly patients is the classic presentation. Chronic lymphedema-associated angiosarcoma (Stewart-Treves syndrome) occurs in the chronically swollen limb after axillary lymph node dissection for breast cancer.
Typical Treatment Roadmap
Detection
Symptoms and initial checkup.
Diagnosis
Biopsy and clinical imaging.
Treatment
Therapy (Surgery, Chemo, etc.)
Monitoring
Follow-up and recovery.
Clinical Manifestation (Main Symptoms)
Clinically, the initial presentation of Angiosarcoma often manifests with Fatigue, Lump, Pain and Bleeding.
Advanced Stage Signs (Warning)
Scalp: multifocal bruise-like lesions or nodules that bleed easily. Breast: rapidly growing mass or skin discoloration in previously irradiated field. Liver: abdominal pain and hepatomegaly. All sites: rapid growth, satellite lesions, and early hematogenous metastases to lungs.
Diagnostic Procedures
Biopsy with immunohistochemistry (CD31, CD34, ERG positivity), MRI for extent of cutaneous disease, CT for visceral staging, and PET-CT for metastatic assessment. MYC amplification differentiates radiation-associated from primary angiosarcoma.
Medical Risk Factors
Chronic lymphedema (Stewart-Treves syndrome), prior radiation therapy (breast, chest wall), environmental vinyl chloride and thorotrast exposure (hepatic angiosarcoma), chronic sun exposure (scalp/face), and foreign body implants (rarely).
Therapeutic Approach
Wide surgical excision (challenging due to multifocal growth pattern). Radiation therapy for scalp angiosarcoma. Paclitaxel-based chemotherapy (weekly paclitaxel shows anti-angiogenic activity). Doxorubicin for advanced disease. Targeted anti-angiogenic agents (pazopanib, bevacizumab). Propranolol (beta-blocker) under investigation as adjunctive therapy.
Medical Breakthroughs & Hope
Weekly paclitaxel has shown significant anti-tumor activity in angiosarcoma, providing a well-tolerated systemic option. Anti-angiogenic therapies targeting the tumor's vascular nature are a rational approach showing promise. Multi-disciplinary management at specialized centers optimizes outcomes.
Prognosis & Efficacy72%
The 5-year survival for angiosarcoma is approximately 30-40% overall due to its aggressive biology, multifocal growth, and tendency for early metastasis. Localized cutaneous disease treated with surgery and radiation has better outcomes (50-60%). Radiation-associated and hepatic angiosarcomas have the worst prognosis.
Myth vs. Clinical Reality
Myth / Fiction
Purple skin lesions in elderly people are just age spots.
Fact / Reality
While most skin changes in elderly people are benign, persistent, expanding bruise-like or purple lesions — especially on the scalp — should be biopsied to rule out angiosarcoma.
Myth / Fiction
Angiosarcoma is too rare to have treatment.
Fact / Reality
Despite its rarity, effective treatments exist including surgery, radiation, taxane chemotherapy, and anti-angiogenic agents. Specialized centers have accumulated meaningful experience.
Frequently Asked Questions (FAQ)
Why does angiosarcoma look like a bruise?
Because it arises from blood vessel cells, angiosarcoma can appear as purplish, bruise-like patches. Any persistent 'bruise' on the scalp or face of an elderly person that doesn't heal should be biopsied.
Can radiation cause angiosarcoma?
Yes, but rarely. Post-radiation angiosarcoma, most commonly in the breast after radiation for breast cancer, occurs in less than 0.5% of irradiated patients, typically 5-10 years after treatment.
What is Stewart-Treves syndrome?
Angiosarcoma arising in a chronically lymphedematous limb, classically after axillary dissection for breast cancer. It is extremely rare but underscores the importance of managing chronic lymphedema.
How is scalp angiosarcoma treated?
Typically with a combination of wide excision and radiation. Margins are often difficult to define clinically, and radiation helps control microscopic residual disease. Systemic therapy is added for advanced cases.
Is it related to common hemangiomas?
No. Hemangiomas are benign vascular tumors extremely common in infants and children. Angiosarcoma is a rare malignant endothelial tumor with completely different biology.